Latest news for Quantum Cap (OTC:QTCI) Stock

Quantum Capital Inc is an Australian company. The company owns Loan Base Pty Ltd, an Australian company with the mission of providing clients with personalized lending solutions that achieve their goals through premium, online, exclusive, convenient, and tailored lending solutions intermediary platforms.

Equities

News

Penny Stocks

Markets

General

QTCI

REPYY

Repsol S.A.(OTC: REPYY) joins the U.S. onshore wind market by acquiring renewable energy platform ConnectGen, with a 20,000 MW pipeline and development capabilities, for $768 million. 

Repsol Dives Into US Wind Market With ConnectGen Acquisition Worth $768M

QUANTUM CAPITAL INC by Quantum Capital Inc.

Quantum Capital Inc

Guidance

Federal Realty Investment Sees FY24 FFO $6.70-$6.88 Vs $6.80 Est.

Sprout Social Sees Q3 Adj. EPS $0.12-$0.13 vs $0.12 Est., Sees Total Revenue $101.9M-$102.1M vs $101.89M Est.

Merit Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.87 by 5.75 percent. The company reported quarterly sales of $338.00 million which beat the analyst consensus estimate of $334.55 million by 1.03 percent. This is a 5.61 percent increase over sales of $320.06 million the same period last year.

Earnings

Earnings Beats

MMSI

Merit Medical Systems Q2 2024 Adj EPS $0.92 Beats $0.87 Estimate, Sales $338.00M Beat $334.55M Estimate

Arcosa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACA#NYSE">ACA</a>) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.83 by 9.64 percent. This is a 19.74 percent increase over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $664.700 million which beat the analyst consensus estimate of $661.540 million by 0.48 percent. This is a 13.66 percent increase over sales of $584.800 million the same period last year.

Arcosa Q2 2024 Adj. EPS $0.91 Beats $0.83 Estimate, Sales $664.700M Beat $661.540M Estimate

Vir Biotechnology Lowers FY 2024 Operating Expense Guidance To $580-$610M Due To Workforce Restructuring And Phasing Out Influenza, COVID-19, And T Cell-Based Viral Vector Programs; Includes $90 - $80M In Stock-Based Compensation And $40 - $30M In Restructuring Charges; Excludes Sanofi Transaction Impact, To Be Updated In Q3 2024 Earnings; Approximately 3% Of GAAP Operating Expense Funded By Grants

Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.25 by 56 percent. This is a 1850 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $284.35 million which beat the analyst consensus estimate of $275.25 million by 3.30 percent. This is a 24.42 percent increase over sales of $228.54 million the same period last year.

PCOR

Procore Technologies Q2 Adj $0.39 Beats $0.25 Estimate, Sales $284.35M Beat $275.25M Estimate

Research Frontiers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFR#NASDAQ">REFR</a>) reported $489.59 thousand in sales this quarter. This is a 164.59 percent increase over sales of $185.04 thousand the same period last year.

REFR

Research Frontiers Q2 Sales $489.59K Up From $185.04K YoY

United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.77 by 9.09 percent. The company reported quarterly sales of $4.12 billion which beat the analyst consensus estimate of $4.02 billion by 2.43 percent. This is a 17.77 percent decrease over sales of $5.01 billion the same period last year.

United States Steel Q2 2024 Adj EPS $0.84 Beats $0.77 Estimate, Sales $4.12B Beat $4.02B Estimate

Guidance
We confirm our guidance for both adjusted earnings per share and dividend payout ratio. We continue to expect annual adjusted earnings per share to grow at a compounded annual rate of 8% to 10% from 2024 to 2026, relative to the 2023 baseline of $2.23 per share, which is equivalent to a 2026 midpoint of $2.89 per share. We also expect distributions of annual dividends per share from 2024 to 2026 at a payout ratio of between 60% and 70% of annual adjusted earnings per share. This guidance reflects our judgments and estimates of (i) yield on our existing portfolio; (ii) yield on incremental portfolio investments, inclusive of our existing pipeline; (iii) the volume and profitability of transactions; (iv) amount, timing, and costs of debt and equity capital to fund new investments; (v) changes in costs and expenses reflective of our forecasted operations; and (vi) the general interest rate and market environment. In addition, distributions are subject to approval by our Board of Directors on a quarterly basis. We have not provided GAAP guidance as discussed in the Forward-Looking Statements section of this press release.

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HA Sustainable Infrastructure Capital Continues To Expect Annual Adj. EPS To Grow At A Compounded Annual Rate Of 8%-10% From 2024-2026, Relative To The 2023 Baseline Of $2.23 Per Share, Which Is Equivalent To A 2026 Midpoint Of $2.89 Per Share.

ACCO

ACCO Brands Sees Q3 FY24 Adj. EPS $0.21-$0.24 vs $0.28 Est., Sees FY24 Adj. EPS $1.04-$1.09 vs $1.04 Est.

Vir Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.90) by 13.33 percent. The company reported quarterly sales of $3.10 million which missed the analyst consensus estimate of $7.50 million by 58.65 percent. This is a 18.36 percent decrease over sales of $3.80 million the same period last year.

Earnings Misses

Vir Biotechnology Q2 2024 Adj EPS $(1.02) Misses $(0.90) Estimate, Sales $3.10M Miss $7.50M Estimate

Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) reported quarterly earnings of $3.39 per share which missed the analyst consensus estimate of $3.45 by 1.74 percent.

Prudential Financial Q2 2024 Adj. EPS $3.39 Misses $3.45 Estimate

TD Cowen analyst Andrew Charles reiterates Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) with a Buy and maintains $125 price target.

Price Target

Reiteration

Analyst Ratings

SHAK

TD Cowen Reiterates Buy on Shake Shack, Maintains $125 Price Target

Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.79 by 1.27 percent. The company reported quarterly sales of $1.20 billion which beat the analyst consensus estimate of $1.19 billion by 0.54 percent. This is a 8.59 percent increase over sales of $1.11 billion the same period last year.

Ventas Q2 2024 FFO $0.80 Beats $0.79 Estimate, Sales $1.20B Beat $1.19B Estimate

Hannon Armstrong (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HASI#NYSE">HASI</a>) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.57 by 10.53 percent. This is a 18.87 percent increase over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $62.78 million which missed the analyst consensus estimate of $71.55 million by 12.26 percent. This is a 30.19 percent increase over sales of $48.22 million the same period last year.

Hannon Armstrong Q2 Adj $0.63 Beats $0.57 Estimate, Sales $62.78M Miss $71.55M Estimate

OneSpan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSPN#NASDAQ">OSPN</a>) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.16 by 93.75 percent. This is a 272.22 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $60.924 million which beat the analyst consensus estimate of $55.569 million by 9.64 percent. This is a 9.31 percent increase over sales of $55.733 million the same period last year.

OSPN

OneSpan Q2 2024 Adj. EPS $0.31 Beats $0.16 Estimate, Sales $60.924M Beat $55.569M Estimate

Air Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) reported quarterly earnings of $1.23 per share which beat the analyst consensus estimate of $0.93 by 32.26 percent. This is a 22.15 percent decrease over earnings of $1.58 per share from the same period last year. The company reported quarterly sales of $667.29 million which missed the analyst consensus estimate of $684.97 million by 2.58 percent. This is a 0.83 percent decrease over sales of $672.90 million the same period last year.

Air Lease Q2 Adj $1.23 Beats $0.93 Estimate, Sales $667.29M Miss $684.97M Estimate

MATX

Matson Expects Q3 2024 Ocean Transportation Operating Income To Be Significantly Higher Than $118.2M Last Year; Q4 2024 Operating Income Expected To Be Moderately Higher Than $66.4M In Q4 2023

Longboard Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBPH#NASDAQ">LBPH</a>) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.45) by 24.44 percent. This is a 13.85 percent increase over losses of $(0.65) per share from the same period last year.

LBPH

Longboard Pharmaceuticals Q2 2024 GAAP EPS $(0.56) Misses $(0.45) Estimate

Civitas Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) reported quarterly earnings of $2.06 per share which missed the analyst consensus estimate of $2.81 by 26.69 percent. The company reported quarterly sales of $1.312 billion which missed the analyst consensus estimate of $1.346 billion by 2.53 percent. This is a 98.63 percent increase over sales of $660.526 million the same period last year.

CIVI

Civitas Resources Q2 2024 Adj. EPS $2.06 Misses $2.81 Estimate, Sales $1.312B Miss $1.346B Estimate

Quantum Cap

Repsol S.A.(OTC:<a class="ticker" href="https://www.benzinga.com/stock/REPYY#OTC">REPYY</a>) joins the U.S. onshore wind market by acquiring renewable energy platform&nbsp;ConnectGen, with a 20,000 MW pipeline and development capabilities, for $768 million.&nbsp;

The acquisition of ConnectGen from Quantum Capital Group is a new milestone in Repsol Renewables&#39; strategy to strengthen its position as a global player in the renewable energy business.

For 2023, the company plans to allocate 35% of its&nbsp;<a class="editor-rtfLink" href="https://www.repsol.com/en/shareholders-and-investors/financial-information/quarterly-results/index.cshtml" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">investments&nbsp;</a>to low-carbon projects. The fiscal contribution stood at &euro;7.343 billion in the year&#39;s first half. Repsol issued most of its investments in the first half of the year to projects in Spain (43%) and the U.S. (39%).

Also Read:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/markets/equities/23/05/32553202/repsol-mulls-selling-49-stake-in-spanish-wind-farm-and-photovoltaic-power-plants" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">Repsol Mulls Selling 49% Stake In Spanish Wind Farm And Photovoltaic Power Plants</a>

Through this transaction, Repsol will add an onshore wind power growth platform in the U.S. that complements Hecate Enegy&#39;s solar &amp; storage development capabilities.

The deal reinforces its international portfolio to support its strategic target of 20,000 MW of installed capacity by 2030.

Also See:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/markets/equities/23/05/32445107/repsol-spreads-footprint-in-italy-with-first-renewable-project" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">Repsol Spreads Footprint In Italy With First Renewable Project</a>

&quot;This transaction is another step in our firm commitment to transforming our industry and becoming a zero net emissions company by 2050, while maintaining our profitable growth, diversification and multi-energy focus and ensuring shareholder returns. The addition of ConnectGen accelerates our commitment to renewable generation in one of the markets with the greatest potential for future growth. In that sense, bringing on board its valuable team of experts is key to ensure our successful future growth with robust profitability in the market,&quot; explains Josu Jon Imaz, CEO of Repsol.

Price Action:&nbsp;REPYY shares closed lower by 0.58% to $15.53 on Thursday.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Quantum Cap

News

Latest news for Quantum Cap (OTC:QTCI) Stock

Friday, September 08, 2023